|
|
|
― |
|
|
|
―
|
|
|
―
|
― |
|
イソプロピルウノプロストン点眼液0.12%「ニッテン」
先発品名:レスキュラ点眼液0.12%
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
販売中止
イソプロピルウノプロストンPF点眼液0.12%「日点」
先発品名:レスキュラ点眼液0.12%
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
|
―
|
― |
|
|
|
|
― |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
―
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
|
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
― |
―
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
―
|
― |
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
―
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
―
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
新発売
タフルプロスト点眼液0.0015%「日点」
先発品名:タプロス点眼液0.0015%
|
|
|
〇 |
|
|
|
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
|
|
|
|
|
― |
―
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
― |
―
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
― |
―
|
|
|
―
|
|
―
|
|
|
|
先発品名:ハイパジールコーワ点眼液0.25%/ニプラノール点眼液0.25%
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
先発品名:ハイパジールコーワ点眼液0.25%/ニプラノール点眼液0.25%
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
|
|
|
― |
|
|
|
―
|
―
|
―
|
―
|
|
|
|
|
|
― |
―
|
|
|
―
|
―
|
|
―
|
|
|
ヒアルロン酸ナトリウム点眼液0.1%「Nitten」
先発品名:ヒアレイン点眼液0.1%
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
|
―
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
|
|
|
|
|
|
―
|
|
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
|
― |
|
ベタメタゾンリン酸エステルNa・PF眼耳鼻科用液0.1%「日点」
先発品名:リンデロン点眼・点耳・点鼻液0.1%
|
|
|
〇 |
|
|
|
―
|
|
|
|
|
|
|
|
|
― |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
―
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
|
―
|
― |
|
|
|
|
〇 |
|
|
|
|
|
|
|
|
|
|
|
|
〇 |
|
|
|
|
|
|
|
|
|
|
|
|
〇 |
|
|
|
|
|
|
|
|
|
|
|
|
〇 |
―
|
|
|
―
|
|
―
|
|
― |
|
|
|
|
〇 |
―
|
|
|
―
|
|
|
|
― |
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|
|
|
|
〇 |
|
|
|
―
|
|
―
|
|
|
|